Levin Capital Strategies, L.P. Alpha Tau Medical Ltd. Transaction History
Levin Capital Strategies, L.P.
- $990 Million
- Q2 2025
A detailed history of Levin Capital Strategies, L.P. transactions in Alpha Tau Medical Ltd. stock. As of the latest transaction made, Levin Capital Strategies, L.P. holds 192,514 shares of DRTS stock, worth $591,017. This represents 0.06% of its overall portfolio holdings.
Number of Shares
192,514
Previous 222,514
13.48%
Holding current value
$591,017
Previous $558,000
7.53%
% of portfolio
0.06%
Previous 0.06%
Shares
9 transactions
Others Institutions Holding DRTS
# of Institutions
28Shares Held
1.55MCall Options Held
0Put Options Held
0-
Hoyle Cohen, LLC269KShares$826,1000.05% of portfolio
-
High Tower Advisors, LLC Chicago, IL231KShares$708,2610.0% of portfolio
-
Kovitz Investment Group Partners, LLC226KShares$694,8020.0% of portfolio
-
ETF Managers Group, LLC Summit, NJ66.3KShares$203,6200.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il59.8KShares$183,7330.0% of portfolio
About Alpha Tau Medical Ltd.
- Ticker DRTS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,011,296
- Market Cap $212M
- Description
- Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast canc...